Person

Greg C. Garland

Director, Amgen

Current S&P 500 boards
1
Current roles
1
Open-market buys
$0
Open-market sales
$75.7M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

  • PSX
    Phillips 66
    DirectorExecutive Chairman
    2016 or earlier – last filing Feb 2024

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Aug 7, 2023PSXSale169,400$111.44$18.9M
Jun 9, 2022PSXSale146,700$109.70$16.1M
Feb 7, 2022PSXSale126,300$88.47$11.2M
Mar 11, 2021PSXSale78,969$88.02$7.0M
Mar 11, 2021PSXSale79,531$88.97$7.1M
Feb 20, 2019PSXSale42,728$97.61$4.2M
Nov 10, 2016PSXSale12,165$83.48$1.0M
Nov 10, 2016PSXSale64,000$83.48$5.3M
Jun 3, 2016PSXSale2,900$80.52$234K
Jun 3, 2016PSXSale59,600$79.92$4.8M

SEC reporting-owner ID (CIK) 1503107 · all filings on EDGAR